The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intranasal Drug And Vaccine Delivery Device Market Research Report 2025
Synopsis
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The global Intranasal Drug And Vaccine Delivery Device market was valued at US$ 1143 million in 2023 and is anticipated to reach US$ 1544.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intranasal Drug And Vaccine Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug And Vaccine Delivery Device.
Report Scope
The Intranasal Drug And Vaccine Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intranasal Drug And Vaccine Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Drug And Vaccine Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Teva Pharmaceuticals
Aptar Pharma
UCB
Teleflex
3M
Bespak
OptiNose
Intersect
Segment by Type
Powder Delivery Device
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Others
Segment by Application
Respiratory Disorders
Neurological Disorder
Vaccination
Pain Management
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intranasal Drug And Vaccine Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intranasal Drug And Vaccine Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The global Intranasal Drug And Vaccine Delivery Device market was valued at US$ 1143 million in 2023 and is anticipated to reach US$ 1544.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intranasal Drug And Vaccine Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug And Vaccine Delivery Device.
Report Scope
The Intranasal Drug And Vaccine Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intranasal Drug And Vaccine Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Drug And Vaccine Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Teva Pharmaceuticals
Aptar Pharma
UCB
Teleflex
3M
Bespak
OptiNose
Intersect
Segment by Type
Powder Delivery Device
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Others
Segment by Application
Respiratory Disorders
Neurological Disorder
Vaccination
Pain Management
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intranasal Drug And Vaccine Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intranasal Drug And Vaccine Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intranasal Drug And Vaccine Delivery Device Market Overview
1.1 Product Overview and Scope of Intranasal Drug And Vaccine Delivery Device
1.2 Intranasal Drug And Vaccine Delivery Device Segment by Type
1.2.1 Global Intranasal Drug And Vaccine Delivery Device Market Value Comparison by Type (2024-2030)
1.2.2 Powder Delivery Device
1.2.3 Liquid Delivery Device
1.2.4 Pressurized Metered Dose Inhaler
1.2.5 Others
1.3 Intranasal Drug And Vaccine Delivery Device Segment by Application
1.3.1 Global Intranasal Drug And Vaccine Delivery Device Market Value by Application: (2024-2030)
1.3.2 Respiratory Disorders
1.3.3 Neurological Disorder
1.3.4 Vaccination
1.3.5 Pain Management
1.3.6 Others
1.4 Global Intranasal Drug And Vaccine Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug And Vaccine Delivery Device Revenue 2019-2030
1.4.2 Global Intranasal Drug And Vaccine Delivery Device Sales 2019-2030
1.4.3 Global Intranasal Drug And Vaccine Delivery Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intranasal Drug And Vaccine Delivery Device Market Competition by Manufacturers
2.1 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intranasal Drug And Vaccine Delivery Device Average Price by Manufacturers (2019-2024)
2.4 Global Intranasal Drug And Vaccine Delivery Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Product Type & Application
2.7 Intranasal Drug And Vaccine Delivery Device Market Competitive Situation and Trends
2.7.1 Intranasal Drug And Vaccine Delivery Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intranasal Drug And Vaccine Delivery Device Players Market Share by Revenue
2.7.3 Global Intranasal Drug And Vaccine Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intranasal Drug And Vaccine Delivery Device Retrospective Market Scenario by Region
3.1 Global Intranasal Drug And Vaccine Delivery Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intranasal Drug And Vaccine Delivery Device Global Intranasal Drug And Vaccine Delivery Device Sales by Region: 2019-2030
3.2.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Region: 2019-2024
3.2.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Region: 2025-2030
3.3 Global Intranasal Drug And Vaccine Delivery Device Global Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2019-2030
3.3.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2019-2024
3.3.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2025-2030
3.4 North America Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.4.1 North America Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intranasal Drug And Vaccine Delivery Device Sales by Country (2019-2030)
3.4.3 North America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.5.1 Europe Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intranasal Drug And Vaccine Delivery Device Sales by Country (2019-2030)
3.5.3 Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.6.1 Asia Pacific Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intranasal Drug And Vaccine Delivery Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Intranasal Drug And Vaccine Delivery Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intranasal Drug And Vaccine Delivery Device Sales by Country (2019-2030)
3.7.3 Latin America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2019-2030)
4.1.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2019-2024)
4.1.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2025-2030)
4.1.3 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2019-2030)
4.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2019-2030)
4.2.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2019-2024)
4.2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2025-2030)
4.2.3 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Type (2019-2030)
4.3 Global Intranasal Drug And Vaccine Delivery Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2019-2030)
5.1.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2019-2024)
5.1.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2025-2030)
5.1.3 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2019-2030)
5.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2019-2030)
5.2.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2019-2024)
5.2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2025-2030)
5.2.3 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Application (2019-2030)
5.3 Global Intranasal Drug And Vaccine Delivery Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Aptar Pharma
6.3.1 Aptar Pharma Corporation Information
6.3.2 Aptar Pharma Description and Business Overview
6.3.3 Aptar Pharma Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aptar Pharma Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.3.5 Aptar Pharma Recent Developments/Updates
6.4 UCB
6.4.1 UCB Corporation Information
6.4.2 UCB Description and Business Overview
6.4.3 UCB Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.4.5 UCB Recent Developments/Updates
6.5 Teleflex
6.5.1 Teleflex Corporation Information
6.5.2 Teleflex Description and Business Overview
6.5.3 Teleflex Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teleflex Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.5.5 Teleflex Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 3M Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Bespak
6.6.1 Bespak Corporation Information
6.6.2 Bespak Description and Business Overview
6.6.3 Bespak Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bespak Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.7.5 Bespak Recent Developments/Updates
6.8 OptiNose
6.8.1 OptiNose Corporation Information
6.8.2 OptiNose Description and Business Overview
6.8.3 OptiNose Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 OptiNose Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.8.5 OptiNose Recent Developments/Updates
6.9 Intersect
6.9.1 Intersect Corporation Information
6.9.2 Intersect Description and Business Overview
6.9.3 Intersect Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Intersect Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.9.5 Intersect Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intranasal Drug And Vaccine Delivery Device Industry Chain Analysis
7.2 Intranasal Drug And Vaccine Delivery Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Drug And Vaccine Delivery Device Production Mode & Process
7.4 Intranasal Drug And Vaccine Delivery Device Sales and Marketing
7.4.1 Intranasal Drug And Vaccine Delivery Device Sales Channels
7.4.2 Intranasal Drug And Vaccine Delivery Device Distributors
7.5 Intranasal Drug And Vaccine Delivery Device Customers
8 Intranasal Drug And Vaccine Delivery Device Market Dynamics
8.1 Intranasal Drug And Vaccine Delivery Device Industry Trends
8.2 Intranasal Drug And Vaccine Delivery Device Market Drivers
8.3 Intranasal Drug And Vaccine Delivery Device Market Challenges
8.4 Intranasal Drug And Vaccine Delivery Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
